Clinical Trial Update: ALPINE: Maintenance Letrozole/Abemaciclib [Phase 2]

View source ↗

Summary

Phase 2 trial update for ALPINE evaluating maintenance letrozole plus abemaciclib in endometrial cancer and recurrent endometrial cancer; study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Letrozole (letrozole)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Endometrial Cancer, Recurrent Endometrial Cancer | Phase 2 | Status: RECRUITING